Literature DB >> 29407341

Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy.

Arunkumar Pitchaimani1, Tuyen Duong Thanh Nguyen2, Santosh Aryal3.   

Abstract

Therapeutic efficacy of a systemic drug delivery largely depends on the targeting design of the delivery system, which tackles with circulatory traffic and prevents the nonspecific distribution of the drug in the wide range of vital organs. A drawing attention has been given to a biomimetic cloaking of the synthetic drug delivery nanoparticle using mammalian cell-ghosts, which has shown the installment of the biological complexity of the original cells thereby acting as naïve cells, to precisely delivery drug to the intended target. Align towards this direction; we developed a membrane camouflage fusogenic liposomal delivery system "NKsome" for targeted tumor therapy using Natural Killer (NK) cell-ghost, which naturally undergoes immunosurveillance of diseased/stress cells. The engineered NKsome shows successful retention of NK cell membrane-associated targeting protein on its surface. With its excellent biocompatibility, NKsome shows a higher affinity towards cancer than normal cells as demonstrated by in vitro flow-passage assay, and exhibits enhanced tumor homing efficiency in-vivo with an extended plasma residence time of 18 h. Moreover, the therapeutic potential of doxorubicin-loaded NKsome shows promising antitumor activity in vivo against MCF-7 induced tumor model. Overall results illustrate the therapeutic advantages of NK cell biomimicry capable of communicating like immune cells for cooperative drug delivery.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomimetic; Cell membrane; Doxorubicin; Fusogenic liposomes; Natural killer cells; Tumor therapy

Mesh:

Substances:

Year:  2018        PMID: 29407341     DOI: 10.1016/j.biomaterials.2018.01.018

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  29 in total

1.  Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds.

Authors:  Flavia Fontana; Raquél Bartolo; Hélder A Santos
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy.

Authors:  Yongrong Yao; Huachao Chen; Ninghua Tan
Journal:  Acta Pharm Sin B       Date:  2021-10-22       Impact factor: 14.903

Review 3.  Combined strategies for tumor immunotherapy with nanoparticles.

Authors:  K Savitsky; X Yu
Journal:  Clin Transl Oncol       Date:  2019-05-04       Impact factor: 3.405

Review 4.  Chemically Engineered Immune Cell-Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools.

Authors:  Leila Pourtalebi Jahromi; Mohammad-Ali Shahbazi; Aziz Maleki; Amir Azadi; Hélder A Santos
Journal:  Adv Sci (Weinh)       Date:  2021-03-01       Impact factor: 16.806

5.  Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination.

Authors:  Miguel Pereira-Silva; Gaurav Chauhan; Matthew D Shin; Clare Hoskins; Marc J Madou; Sergio O Martinez-Chapa; Nicole F Steinmetz; Francisco Veiga; Ana Cláudia Paiva-Santos
Journal:  Expert Opin Drug Deliv       Date:  2021-06-06       Impact factor: 6.648

Review 6.  Synthetic cells in biomedical applications.

Authors:  Wakana Sato; Tomasz Zajkowski; Felix Moser; Katarzyna P Adamala
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-11-01

7.  Artificial tumor microenvironment regulated by first hemorrhage for enhanced tumor targeting and then occlusion for synergistic bioactivation of hypoxia-sensitive platesomes.

Authors:  Wenhui Tao; Dongyang Zhao; Guanting Li; Lingxiao Li; Songhao Li; Hao Ye; Chutong Tian; Yutong Lu; Shuying Li; Yinghua Sun; Zhonggui He; Jin Sun
Journal:  Acta Pharm Sin B       Date:  2021-08-12       Impact factor: 14.903

8.  Biodistribution of gadolinium- and near infrared-labeled human umbilical cord mesenchymal stromal cell-derived exosomes in tumor bearing mice.

Authors:  Javier Abello; Tuyen Duong Thanh Nguyen; Ramesh Marasini; Santosh Aryal; Mark Louis Weiss
Journal:  Theranostics       Date:  2019-04-12       Impact factor: 11.556

Review 9.  Overview of Strategies to Improve Therapy against Tumors Using Natural Killer Cell.

Authors:  Chaopin Yang; Yue Li; Yaozhang Yang; Zhiyi Chen
Journal:  J Immunol Res       Date:  2020-01-21       Impact factor: 4.818

Review 10.  Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy.

Authors:  Ang Gao; Xian-Li Hu; Madiha Saeed; Bin-Fan Chen; Ya-Ping Li; Hai-Jun Yu
Journal:  Acta Pharmacol Sin       Date:  2019-08-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.